Achaogen (AKAO) News Today → A.I. is a Tidal Wave - Here’s What to Buy (From Chaikin Analytics) (Ad) Free AKAO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRavi Viswanathan's Net Worthbenzinga.com - February 21 at 7:39 PMCOP28: Climate mums make themselves heard in halls of powerbbc.com - December 28 at 3:41 PMAKAOQ Historical Datainvesting.com - October 25 at 8:47 AMSepterna Strengthens Leadership Team to Advance Novel Small Molecule GPCR Medicines - Yahoo Financefinance.yahoo.com - July 28 at 2:12 PMAn N.J. medical expert warns of the rise of superbugs | Opinion - NJ.comnj.com - June 13 at 5:52 PMFlare Therapeutics Appoints Adrian Jubb as Chief Medical Officer - StreetInsider.comstreetinsider.com - April 28 at 7:53 PMFlare Therapeutics Appoints Adrian Jubb as Chief Medical Officer - Yahoo Financefinance.yahoo.com - April 26 at 12:49 PMCipla Calls Achaogen Claims Over Lost Ch. 11 Sales 'Weak' - Law360law360.com - April 13 at 5:48 PMGreater access to antibiotics is essential for curbing drug resistance - Financial Timesft.com - April 13 at 2:47 AMLife sciences VC 5AM Ventures adds 2 new funds totaling $750M - San Francisco Business Times - The Business Journalsbizjournals.com - April 4 at 5:46 PMShortage of new antibiotics stokes fears of a 'silent pandemic' - The Timesthetimes.co.uk - March 19 at 6:30 PMForever In Love And In Love With Forever: Introducing The World's First True Longevity Couple - Forbesforbes.com - February 14 at 9:57 AMGlobal Urinary Tract Infection Therapeutics Market Size Will Touch USD 11652 Million Mark by 2027, at a 4.56% CAGR - GlobeNewswireglobenewswire.com - February 2 at 12:36 PMApplied Molecular Transport Announces Board Appointments - Yahoo Financefinance.yahoo.com - January 27 at 6:49 PMTo avoid the superbug pandemic, we must fix the business model for new antibiotics - Fortunefortune.com - November 25 at 1:35 PMGlobal Antibiotic Resistance Markets, 2019-2020 & 2021-2027 - Focus on Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies - ResearchAndMarkets.com - Business Wirebusinesswire.com - November 4 at 1:12 PMThe Top In-House Hires Of September - Law360law360.com - October 8 at 8:20 PMGlobal $13.8 Billion Antimicrobial Resistance Market, 2027 | Opportunity Breakdown by Disease, Pathogen, Drug Class, End-user and Region - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 27 at 8:23 AMGlobal Antibody Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 - PRNewswireprnewswire.com - September 16 at 9:38 AMContraFect: Non-Antibiotic Alternative That Could Disrupt The Antibiotic Market - Seeking Alphaseekingalpha.com - September 15 at 8:54 AMCRISPR Biotech Co. Mammoth Hires Sangamo Atty As GC - Law360law360.com - September 9 at 7:20 PMBiotech Dice led by Kevin Judice rolls toward $100M IPO - San Francisco Business Times - San Francisco Business Timesbizjournals.com - August 26 at 9:49 PMCarbapenem-Resistant Enterobacteriaceae Infection Market Insight, Epidemiology and Market Forecast Report 2021-2030 - ResearchAndMarkets.com - Business Wirebusinesswire.com - August 9 at 9:21 AM Get Achaogen News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAO and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here AKAO Media Mentions By Week AKAO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKAO News Sentiment▼0.000.34▲Average Medical News Sentiment AKAO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKAO Articles This Week▼00▲AKAO Articles Average Week Get Achaogen News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cadrenal Therapeutics News Pulmatrix News Ayala Pharmaceuticals News Adial Pharmaceuticals News TFF Pharmaceuticals News Pasithea Therapeutics News Enveric Biosciences News Shuttle Pharmaceuticals News Vaccinex News Can-Fite BioPharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKAO) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achaogen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
